Skip to main content

Corvus Pharmaceuticals, Inc.

CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626971

No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in Corvus Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
0 vs. Q2 2023
Shares held
19.2M
−305.7K (−1.6%) vs. Q2 2023
Total value
$28.0M
−$16.6M (−37.2%) vs. Q2 2023
New holders
10
15 more added
Sold out
10
11 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 52 institutions
Q1 2021: 49 institutionsQ2 2021: 50 institutionsQ3 2021: 61 institutionsQ4 2021: 62 institutionsQ1 2022: 57 institutionsQ2 2022: 47 institutionsQ3 2022: 48 institutionsQ4 2022: 42 institutionsQ1 2023: 37 institutionsQ2 2023: 52 institutionsQ3 2023: 52 institutionsQ4 2023: 48 institutionsQ1 2024: 47 institutionsQ2 2024: 47 institutionsQ3 2024: 62 institutionsQ4 2024: 86 institutionsQ1 2025: 88 institutionsQ2 2025: 92 institutionsQ3 2025: 103 institutionsQ4 2025: 124 institutionsQ1 2026: 164 institutionsQ2 2026: 173 institutions
Value heldQ3 2023: $28.0M
Q1 2021: $62.8MQ2 2021: $63.2MQ3 2021: $136.4MQ4 2021: $66.7MQ1 2022: $44.9MQ2 2022: $25.4MQ3 2022: $18.1MQ4 2022: $18.2MQ1 2023: $18.9MQ2 2023: $44.6MQ3 2023: $28.0MQ4 2023: $33.8MQ1 2024: $31.9MQ2 2024: $50.2MQ3 2024: $158.5MQ4 2024: $202.0MQ1 2025: $115.4MQ2 2025: $167.1MQ3 2025: $312.7MQ4 2025: $359.4MQ1 2026: $1.02BQ2 2026: $1.06B
Institutions holding CRVS and their total value by quarter
QuarterHoldersValue
Q2 2026173$1.06B
Q1 2026164$1.02B
Q4 2025124$359.4M
Q3 2025103$312.7M
Q2 202592$167.1M
Q1 202588$115.4M
Q4 202486$202.0M
Q3 202462$158.5M
Q2 202447$50.2M
Q1 202447$31.9M
Q4 202348$33.8M
Q3 202352$28.0M
Q2 202352$44.6M
Q1 202337$18.9M
Q4 202242$18.2M
Q3 202248$18.1M
Q2 202247$25.4M
Q1 202257$44.9M
Q4 202162$66.7M
Q3 202161$136.4M
Q2 202150$63.2M
Q1 202149$62.8M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q2 2023.

Institutions holding CRVS in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC6,943,654$10.1M0.23%00.0%Unchanged
Adams Street Partners LLC3,275,616$4.78M1.67%00.0%Unchanged
Samlyn Capital, LLC2,405,764$3.51M0.06%+299,834+14.2%Added
BVF Inc1,370,947$2.00M0.05%00.0%Unchanged
Vanguard Group Inc1,346,932$1.97M0.00%+45,707+3.5%Added
BlackRock Inc.521,251$761.0K0.00%−11,130−2.1%Reduced
Renaissance Technologies LLC421,743$616.0K0.00%−67,930−13.9%Reduced
Geode Capital Management, LLC360,380$526.3K0.00%+18,301+5.3%Added
Towerview LLC342,478$500.0K0.33%+137,478+67.1%Added
Two Sigma Investments, LP273,007$398.6K0.00%+18,753+7.4%Added
Two Sigma Advisers, LP248,900$363.4K0.00%+70,100+39.2%Added
Marshall Wace, LLP198,220$289.4K0.00%−100,920−33.7%Reduced
Morgan Stanley192,506$281.1K0.00%+52,871+37.9%Added
Bridgeway Capital Management, LLC149,300$218.0K0.01%+40,000+36.6%Added
State Street Corp138,403$202.1K0.00%00.0%Unchanged
Susquehanna International Group, LLP127,968$186.8K0.00%−67,284−34.5%Reduced
Millennium Management LLC108,024$157.7K0.00%+108,024New
Connor, Clark & Lunn Investment Management Ltd.70,883$103.5K0.00%−13,485−16.0%Reduced
JPMorgan Chase & Co69,907$102.1K0.00%+68,706+5,720.7%Added
MYDA Advisors LLC68,814$100.5K0.04%−31,186−31.2%Reduced
Northern Trust Corp65,017$94.9K0.00%00.0%Unchanged
Jackson Square Capital, LLC63,773$93.1K0.04%00.0%Unchanged
Hikari Power Ltd49,959$73.0K0.01%00.0%Unchanged
Goldman Sachs Group Inc49,324$72.0K0.00%−44,987−47.7%Reduced
Simplex Trading, LLC39,493$57.0K0.00%+27,964+242.6%Added
Group One Trading, L.P.27,099$39.6K0.00%+27,099New
Tower Research Capital LLC (TRC)24,737$36.1K0.00%+4,194+20.4%Added
Bank of New York Mellon Corp21,219$31.0K0.00%00.0%Unchanged
Commerce Bank20,000$29.2K0.00%00.0%Unchanged
XTX Topco Ltd19,244$28.1K0.00%+19,244New
American Century Companies Inc18,754$27.4K0.00%+18,754New
Virtu Financial LLC17,366$25.0K0.00%−8,176−32.0%Reduced
Charles Schwab Investment Management Inc15,668$22.9K0.00%00.0%Unchanged
Invesco Ltd.15,617$22.8K0.00%+4,672+42.7%Added
Dimensional Fund Advisors LP14,890$21.7K0.00%−43,222−74.4%Reduced
Barclays PLC13,682$20.0K0.00%+13,681+1,368,100.0%Added
HRT Financial LP13,050$19.0K0.00%+13,050New
Gillespie Robinson & Grimm Inc11,480$16.8K0.00%+11,480New
Two Sigma Securities, LLC11,232$16.4K0.00%+11,232New
Whittier Trust Co of Nevada Inc11,200$16.4K0.00%+7,000+166.7%Added
Masso Torrence Wealth Management Inc.10,000$14.6K0.01%+10,000New
UBS Group AG6,700$9.78K0.00%00.0%Unchanged
Northwest Capital Management Inc3,397$4.96K0.00%00.0%Unchanged
Bank of America Corp3,172$4.63K0.00%−1,907−37.5%Reduced
Advisor Group Holdings, Inc.2,400$3.50K0.00%+1,300+118.2%Added
FMR LLC1,101$1.61K0.00%+1,101New
Natixis800$1.17K0.00%00.0%Unchanged
Rhumbline Advisers791$1.15K0.00%00.0%Unchanged
Wells Fargo & Company247$3610.00%−1−0.4%Reduced
Citadel Advisors LLC183$2670.00%+183New
IFP Advisors, Inc24$350.00%00.0%Unchanged
Parallel Advisors, LLC20$290.00%00.0%Unchanged
Artal Group S.A.0$00.00%−500,000−100.0%Sold out
CHI Advisors LLC0$00.00%−200,000−100.0%Sold out
Cornercap Investment Counsel Inc0$00.00%−97,248−100.0%Sold out
Acadian Asset Management LLC0$00.00%−58,069−100.0%Sold out
Jane Street Group, LLC0$00.00%−35,118−100.0%Sold out
Squarepoint Ops LLC0$00.00%−17,082−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−15,552−100.0%Sold out
Tucker Asset Management LLC0$00.00%−12,871−100.0%Sold out
Difesa Capital Management, LP0$00.00%−10,000−100.0%Sold out
NewSquare Capital LLC0$00.00%−220−100.0%Sold out